Evidence for a role of GABAergic and glutamatergic signalling in the rat basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia.  The International Association for Cannabinoids as Medicines (IACM) 6th Conference and 5th European Workshop on Cannabinoids as Medicine

David Finn

Evidence for a role of GABAergic and glutamatergic signalling in the rat basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia. The International Association for Cannabinoids as Medicines (IACM) 6th Conference and 5th European Workshop on Cannabinoids as Medicine

David Finn

Pharmacology and Therapeutics

Research output: Other contribution (Published) › Other contribution

Original language	English (Ireland)
Media of output	Abstract
Publication status	Published - 1 Sept 2011

Cite this

@misc{dc53d5dd1de9467bba83c933e85bc049,

title = "Evidence for a role of GABAergic and glutamatergic signalling in the rat basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia. The International Association for Cannabinoids as Medicines (IACM) 6th Conference and 5th European Workshop on Cannabinoids as Medicine",

author = "David Finn",

year = "2011",

month = sep,

day = "1",

language = "English (Ireland)",

type = "Other",

}

Evidence for a role of GABAergic and glutamatergic signalling in the rat basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia. The International Association for Cannabinoids as Medicines (IACM) 6th Conference and 5th European Workshop on Cannabinoids as Medicine. / Finn, David.
2011.

Research output: Other contribution (Published) › Other contribution

TY - GEN

T1 - Evidence for a role of GABAergic and glutamatergic signalling in the rat basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia. The International Association for Cannabinoids as Medicines (IACM) 6th Conference and 5th European Workshop on Cannabinoids as Medicine

AU - Finn, David

PY - 2011/9/1

Y1 - 2011/9/1

M3 - Other contribution

ER -